BL Pharmtech Corp. (KOSDAQ:065170)
South Korea · Delayed Price · Currency is KRW 5,430.00
+1,250.00 (29.90%)
At close: Feb 13, 2026
BL Pharmtech Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -6,019 | -5,706 | -148.85 | -13,903 | -20,211 | -17,947 |
Depreciation & Amortization | 689.54 | 852.35 | 848.1 | 900.55 | 3,448 | 2,533 |
Loss (Gain) From Sale of Assets | -43.93 | -78.66 | -52.54 | - | -3,032 | -82.28 |
Asset Writedown & Restructuring Costs | 950 | 950 | 2,900 | 5,151 | 16,238 | 13,724 |
Loss (Gain) From Sale of Investments | -17.37 | 180.06 | - | -283.8 | -67.11 | 60.66 |
Loss (Gain) on Equity Investments | 1,651 | 1,505 | 468.95 | 358.97 | - | 5,825 |
Stock-Based Compensation | 4.34 | -5.3 | 20.4 | 39.48 | 19.22 | 184.72 |
Provision & Write-off of Bad Debts | -497.83 | -593.47 | -124.14 | 65.09 | 191.72 | 25.65 |
Other Operating Activities | 950.14 | 140.48 | 3,823 | 4,946 | 7,437 | 3,109 |
Change in Accounts Receivable | 829.01 | 130.62 | -1,313 | 1,083 | -325.77 | -4,556 |
Change in Inventory | 1,330 | 854.11 | 7,741 | -3,320 | 314.38 | -1,842 |
Change in Accounts Payable | 22.37 | -674.82 | 1,514 | -2,906 | 1,776 | 1,895 |
Change in Other Net Operating Assets | 1,316 | -591.29 | -559.25 | -8,182 | -2,691 | 2,875 |
Operating Cash Flow | 1,165 | -3,037 | 7,992 | -10,998 | 3,097 | 5,804 |
Operating Cash Flow Growth | - | - | - | - | -46.64% | 60.11% |
Capital Expenditures | 0 | -1,166 | -312.07 | -1,708 | -587.15 | -17,626 |
Sale of Property, Plant & Equipment | - | - | 161.4 | - | 6,257 | 3,926 |
Cash Acquisitions | - | - | - | - | - | -15,930 |
Divestitures | - | - | 26,264 | - | - | 299.59 |
Sale (Purchase) of Intangibles | -1,007 | -1,000 | -1.5 | -13.94 | -291.27 | -1.37 |
Investment in Securities | -161.08 | 3,714 | -10,817 | -1,459 | -7,102 | -5,336 |
Other Investing Activities | 3,403 | -8,051 | 0 | -192.02 | 2,045 | 950.1 |
Investing Cash Flow | 2,375 | -6,447 | 15,294 | -3,374 | 321.64 | -33,718 |
Short-Term Debt Issued | - | 1,000 | 24,388 | 11,388 | - | 5,167 |
Long-Term Debt Issued | - | - | 6,299 | 500 | 16,373 | 13,680 |
Total Debt Issued | 1,040 | 1,000 | 30,687 | 11,888 | 16,373 | 18,847 |
Short-Term Debt Repaid | - | - | -24,855 | -12,721 | -1,695 | -817.44 |
Long-Term Debt Repaid | - | -389.23 | -23,533 | -1,489 | -8,829 | -320.45 |
Total Debt Repaid | -4,054 | -389.23 | -48,389 | -14,210 | -10,523 | -1,138 |
Net Debt Issued (Repaid) | -3,014 | 610.77 | -17,702 | -2,322 | 5,850 | 17,709 |
Repurchase of Common Stock | -9.66 | -2 | - | - | -0.38 | -0 |
Other Financing Activities | 149.61 | 2,129 | 0 | - | -9.13 | -78.81 |
Financing Cash Flow | -2,874 | 2,738 | -17,702 | -2,322 | 5,840 | 17,630 |
Foreign Exchange Rate Adjustments | -61.23 | 3.01 | -0.46 | -35.05 | 113.13 | -57.98 |
Net Cash Flow | 603.46 | -6,743 | 5,584 | -16,728 | 9,372 | -10,342 |
Free Cash Flow | 1,165 | -4,203 | 7,680 | -12,706 | 2,510 | -11,822 |
Free Cash Flow Margin | 16.69% | -47.74% | 31.31% | -56.41% | 2.97% | -18.00% |
Free Cash Flow Per Share | 43.72 | -157.49 | 287.73 | -476.04 | 95.28 | -531.60 |
Cash Interest Paid | 378.94 | 356.19 | 1,491 | 930.47 | 925.5 | 696.16 |
Cash Income Tax Paid | - | 34.63 | -39.22 | -14.29 | -2.83 | -48.68 |
Levered Free Cash Flow | -1,463 | -7,744 | 7,260 | -11,273 | 4,183 | -21,960 |
Unlevered Free Cash Flow | -827.75 | -7,225 | 8,243 | -9,894 | 5,803 | -20,623 |
Change in Working Capital | 3,497 | -281.37 | 7,382 | -13,324 | -926.44 | -1,628 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.